Khera Amit, McGuire Darren K, Murphy Sabina A, Stanek Harold G, Das Sandeep R, Vongpatanasin Wanpen, Wians Frank H, Grundy Scott M, de Lemos James A
Donald W. Reynolds Cardiovascular Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9047, USA.
J Am Coll Cardiol. 2005 Aug 2;46(3):464-9. doi: 10.1016/j.jacc.2005.04.051.
This study sought to determine whether there are race and gender differences in the distribution of C-reactive protein (CRP) levels.
Few data are available comparing CRP distributions in different race and gender groups. Recent clinical practice recommendations for CRP testing for cardiovascular risk assessment suggest a uniform threshold to define high relative risk (>3 mg/l).
We measured CRP in 2,749 white and black subjects ages 30 to 65 participating in the Dallas Heart Study, a multiethnic, population-based, probability sample, and compared levels of CRP between different race and gender groups.
Black subjects had higher CRP levels than white subjects (median, 3.0 vs. 2.3 mg/l; p < 0.001) and women had higher CRP levels than men (median, 3.3 vs. 1.8 mg/l; p < 0.001). The sample-weight adjusted proportion of subjects with CRP levels >3 mg/l was 31%, 40%, 51%, and 58% in white men, black men, white women, and black women, respectively (p < 0.05 for each group vs. white men). After adjustment for traditional cardiovascular risk factors, estrogen and statin use, and body mass index, a CRP level >3 mg/l remained more common in white women (odds ratio [OR] 1.6; 95% confidence interval [CI] 1.1 to 2.5) and black women (OR 1.7; 95% CI 1.2 to 2.6) but not in black men (OR, 1.3; 95% CI, 0.8 to 1.9) when compared with white men.
Significant race and gender differences exist in the population distribution of CRP. Further research is needed to determine whether race and gender differences in CRP levels contribute to differences in cardiovascular outcomes, and whether thresholds for cardiovascular risk assessment should be adjusted for different race and gender groups.
本研究旨在确定C反应蛋白(CRP)水平分布是否存在种族和性别差异。
关于不同种族和性别组CRP分布比较的数据很少。近期心血管风险评估中CRP检测的临床实践建议提出了一个统一的阈值来定义高相对风险(>3mg/L)。
我们在参与达拉斯心脏研究的2749名30至65岁的白人和黑人受试者中测量了CRP,该研究是一个多民族、基于人群的概率样本,并比较了不同种族和性别组之间的CRP水平。
黑人受试者的CRP水平高于白人受试者(中位数分别为3.0和2.3mg/L;p<0.001),女性的CRP水平高于男性(中位数分别为3.3和1.8mg/L;p<0.001)。CRP水平>3mg/L的样本加权调整比例在白人男性、黑人男性、白人女性和黑人女性中分别为31%、40%、51%和58%(每组与白人男性相比,p<0.05)。在调整了传统心血管危险因素、雌激素和他汀类药物使用以及体重指数后,与白人男性相比,CRP水平>3mg/L在白人女性(优势比[OR]1.6;95%置信区间[CI]1.1至2.5)和黑人女性(OR 1.7;95%CI 1.2至2.6)中仍然更常见,但在黑人男性中并非如此(OR 1.3;95%CI 0.8至1.9)。
CRP的人群分布存在显著的种族和性别差异。需要进一步研究以确定CRP水平的种族和性别差异是否导致心血管结局的差异,以及心血管风险评估的阈值是否应针对不同种族和性别组进行调整。